Hereditary gastric cancer

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:423776
Who is this for?
Show terms as
2FDA treatments31Specialists8Treatment centers2Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hereditary gastric cancer refers to a group of inherited conditions that significantly raise a person's risk of developing cancer in the stomach. Unlike most stomach cancers, which happen by chance, hereditary gastric cancer runs in families and is caused by changes (mutations) in specific genes passed down from parents to children. The most well-known form is called Hereditary Diffuse Gastric Cancer (HDGC), which is linked to mutations in the CDH1 gene. Another form involves hereditary intestinal-type gastric cancer, sometimes connected to Lynch syndrome or other hereditary cancer syndromes. The stomach cancer that develops in these families can be hard to detect early because it often grows in a spread-out pattern beneath the stomach lining rather than forming a single visible lump. This makes it difficult to spot on standard endoscopy. Symptoms may include persistent stomach pain, difficulty swallowing, unexplained weight loss, nausea, and a feeling of fullness after eating only small amounts. Treatment options include close surveillance with regular endoscopies, preventive (prophylactic) total gastrectomy (surgical removal of the stomach) for high-risk individuals, and standard cancer treatments such as surgery, chemotherapy, and targeted therapy if cancer is diagnosed. Early identification through genetic testing is critical, as it allows families to take steps to prevent cancer or catch it at an earlier, more treatable stage.

Also known as:

Key symptoms:

Persistent stomach pain or discomfortUnexplained weight lossDifficulty swallowingFeeling full quickly after eating small amountsNausea or vomitingLoss of appetiteHeartburn or indigestion that does not go awayBloating after mealsBlood in vomit or dark, tarry stoolsFatigue and low energyAnemia (low red blood cell count)

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Dec 2025Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Alliance for Clinical Trials in Oncology — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

2 available

Enhertu

fam-trastuzumab deruxtecan-nxki· Daiichi Sankyo, Inc.■ Boxed Warning
as monotherapy for the treatment of adult patients with locally advanced or metastatic HER2-positive (IHC 3+ or IHC 2+/ISH positive) gastric or gastroesophageal junction adenocarcinoma who have receiv

as monotherapy for the treatment of adult patients with locally advanced or metastatic HER2-positive (IHC 3+ or IHC 2+/ISH positive) gastric or gastroesophageal junction adenocarcinoma who have received a prior trastuzumab-based regimen

CYRAMZA

ramucirumab· Eli Lilly and CompanyOrphan Drug

Treatment of advanced gastric or gastro-esophageal junction adenocarcinoma, as a single agent or in combination with paclitaxel, after prior fluoropyrimidine- or platinium-containing chemotherapy.

No actively recruiting trials found for Hereditary gastric cancer at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hereditary gastric cancer community →

Specialists

Showing 25 of 31View all specialists →
MM
Massimiliano di Pietro, MD
Specialist
PI on 1 active trial
CP
Carlos Pardo
PLANTATION, FL
Specialist
1 Hereditary gastric cancer publication
EC
Elisa Cantú-Germano
Specialist
1 Hereditary gastric cancer publication
IL
Irina Luzko
Specialist
1 Hereditary gastric cancer publication
JC
Joaquín Castillo-Iturra
Specialist
1 Hereditary gastric cancer publication
LM
Leticia Moreira
Specialist
1 Hereditary gastric cancer publication
MO
Mako Okada
Specialist
1 Hereditary gastric cancer publication
LS
Laura Sirmai
Specialist
1 Hereditary gastric cancer publication
FC
Fátima Carneiro
Specialist
1 Hereditary gastric cancer publication
KS
Kenji Sano
Specialist
1 Hereditary gastric cancer publication
TH
Takuma Hayashi
Specialist
1 Hereditary gastric cancer publication
MS
Magali Svrcek
Specialist
1 Hereditary gastric cancer publication
PB
Patrick R Benusiglio
Specialist
1 Hereditary gastric cancer publication
LM
Luigi Ricciardiello, MD
LACONIA, NH
Specialist
PI on 1 active trial
JY
James Yao
Specialist
PI on 2 active trials
BP
Bryson W Katona, MD, PhD
PHILADELPHIA, PA
Specialist
PI on 2 active trials
KP
Kurt Fisher, MD, PhD
OMAHA, NE
Specialist
PI on 1 active trial
JM
Julie Metras
Specialist
1 Hereditary gastric cancer publication
AD
Antoine Dardenne
Specialist
1 Hereditary gastric cancer publication
DE
Diana Enea
Specialist
1 Hereditary gastric cancer publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

2 resources
Enhertu(fam-trastuzumab deruxtecan-nxki)Daiichi Sankyo, Inc.
CYRAMZA(ramucirumab)Eli Lilly and Company

Travel Grants

No travel grants are currently matched to Hereditary gastric cancer.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hereditary gastric cancerForum →

No community posts yet. Be the first to share your experience with Hereditary gastric cancer.

Start the conversation →

Latest news about Hereditary gastric cancer

1 articles
Clinical trialUNITERAREApr 3, 2026
New Recruiting Trial: Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers
Researchers are looking for patients with gastroesophageal cancer (cancer of the food pipe and stomach) that has spread to the brain. This study will compare th
See all news about Hereditary gastric cancer

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Should I have genetic testing, and which genes should be included in the panel?,What is my personal risk of developing gastric cancer based on my family history and test results?,Should I consider prophylactic gastrectomy, and what would life look like after that surgery?,How often should I have surveillance endoscopies, and how reliable are they at finding early cancer?,Should my children or siblings be tested, and at what age?,Are there clinical trials I should know about for hereditary gastric cancer?,What nutritional support and dietary guidance is available if I have surgery?

Common questions about Hereditary gastric cancer

What is Hereditary gastric cancer?

Hereditary gastric cancer refers to a group of inherited conditions that significantly raise a person's risk of developing cancer in the stomach. Unlike most stomach cancers, which happen by chance, hereditary gastric cancer runs in families and is caused by changes (mutations) in specific genes passed down from parents to children. The most well-known form is called Hereditary Diffuse Gastric Cancer (HDGC), which is linked to mutations in the CDH1 gene. Another form involves hereditary intestinal-type gastric cancer, sometimes connected to Lynch syndrome or other hereditary cancer syndromes.

How is Hereditary gastric cancer inherited?

Hereditary gastric cancer follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hereditary gastric cancer typically begin?

Typical onset of Hereditary gastric cancer is adult. Age of onset can vary across affected individuals.

Which specialists treat Hereditary gastric cancer?

25 specialists and care centers treating Hereditary gastric cancer are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.